Home » Topics » BioWorld Science

BioWorld Science
RSS

TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis

July 14, 2021

ENA studies INNA-051 nasal spray in phase I to boost innate immunity against respiratory viruses

July 14, 2021

Barcoding strategy tracks breast cancer metastases

July 14, 2021

FDA clears IND for Kintor's GT-20029 for androgenetic alopecia and acne

July 14, 2021

First cohort of subjects dosed in ASC-42 bridging study in China

July 14, 2021

SFX-01 shown to be effective in in vitro models of blood cancers

July 14, 2021

ACE2 and TLR7 are highly expressed in severe patients with COVID-19

July 14, 2021

XVR-011 shows neutralization activity against the Gamma and Delta variants of SARS-CoV-2

July 14, 2021

Genocea initiates phase I/IIa study of neoantigen-targeted T cell therapy GEN-011

July 14, 2021

Hepion reports phase IIa topline data on CRV-431 in presumed F2 and F3 NASH

July 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...